FindTrial
Sign In

Evaluation of caspase 3 levels in gums of patients with gum diseases before and after gum treatment.

Evaluation of caspase 3 levels in gingival crevicular fluid in chronic periodontitis patients pre and post non-surgical periodontal therapy and compare with healthy control.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/06/014600
Enrollment
40
Registered
2018-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with chronic periodontitis

Interventions

Control Intervention1: caspase 3: comparing caspase 3 levels in GCF pre an post non surgical perioontal treatment

Sponsors

Santo Grace
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with chronic periodontitis

Exclusion criteria

Exclusion criteria: patients with systemic diseases patients under antibiotics for the past 6 months

Design outcomes

Primary

MeasureTime frame
Variation in GCF caspase 3 levels. Reduction in bleeding on probing Reduction in Probing depth Attachment gain Timepoint: 1.assessment at baseline 2.assessment at 3 months—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactSanto Grace

Saveetha Dental College, Saveetha University.

msankari@gmail.com9840285905

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026